bioRxiv Science⌕ Search

Biology subjects

Hengartner, N.

Publications and source records attributed to Hengartner, N..

4 recordsLinked to original sources

Benchmarking Molecular Methods of Protein Engineering and Surveying Protein Search Space to Bolster Artificial Intelligence-Based Designs

Proteins are complex macromolecules that drive functionality in cells across all life on Earth. Protein engineering and AI-based designs facilitate exploration of the vast search space. Herein, we explore and compare mutagenic methodologies in combination with fast and efficient phenotypic evaluation of a pink fluorophore (Magenta) to map protein search space and inform AI-based designer algorithms. We binned mutated variants as neutral, deleterious, or catastrophic based on the observed phenotype and fitness measurement (relative fluorescent units, RFUs). Importantly, we found that for a given fluorophore, about 80% of random mutations were deleterious for the artificially selected phenotype resulting in decreased fitness, 20% were neutral mutations, and 0.8% enhanced the artificially selected phenotype. Using error prone PCR (epPCR), we were able to identify four candidates in the first round and one candidate in the second round of epPCR for enhanced fluorescence and in toto enhanced RFUs by 35% after two rounds of epPCR. We compared these rates of true positive enhanced RFU generated sequences against a state of the art evolutionary algorithm approach and found that biological computation beats it in its current state. We conclude with suggestions for key improvements to enhance algorithm performance in the future. Taken together, we demonstrated that iterative rounds of variant prediction improved our algorithm, and our study can serve as a reference point for future AI driven modeling studies in red fluorescent protein engineering.

bioinformatics↗

An Improved Dataset for Predicting Mammal Infecting Viruses from Genetic Sequence Information

There have been several attempts to develop machine learning (ML) models to identify human infecting viruses from their genomic sequences, with varying degrees of success. Direct comparison between models is problematic, because these models are typically trained and evaluated on different datasets with alter-native data splitting schemes, features, and model performance metrics. In this paper we present a standardized dataset of mammal infecting and non-infecting viral pathogens, refined from the previous work of Mollentze et al. to include the latest literature evidence, roughly doubling the number of curated host-virus records available to the community, and new host target labels, primate and mammal. The new host labels were included for several reasons, including previous reports that classification performance is better at broader taxonomic ranks and the idea that there may be more data for primate infection that might serve as a suitable proxy for zoonotic potential and avoidance of false positives for human infection due to absence of evidence. On this dataset, we report the performance of eight machine learning models for predicting mammal-infecting viruses from their genomic sequences. We find that randomly assigning cases in our improved dataset to training/testing sets, when compared to the original assignments into training/testing in Mollentze et al., increases the overall average ROC AUC of prediction of human infection from 0.663 {+/-} 0.070 to 0.784 {+/-} 0.013, consistent with the reduction in phylogenetic distance between train and test sets (relative entropy change from 3.00 to 0.08). The broadest host category of mammal infection can be predicted most reliably at 0.850 {+/-} 0.020. We share our improved dataset and code to enable standardized comparisons of machine learning methods to predict human host infections. Overall, we have presented preliminary evidence that classification of virus host infection is more tractable at higher taxonomic ranks, that unsurprisingly reducing the phylogenetic distance between training and test sets can improve predictive performance, that peptide kmer features appear to be harmful to out of sample model performance, and we are left with the question of whether models for virus host prediction can reasonably be expected to perform well in out of sample scenarios given the likelihood that viruses do not share a common ancestor. Consistent with this concern, when the data is resampled such that there is no overlap between viral families in training and test sets (relative entropy > 24), models perform no bet-ter than random chance at prediction of human infection regardless of whether kmers are included (ROC AUC 0.50 {+/-} 0.08) or not (ROC AUC 0.50 {+/-} 0.04). Author SummaryDetermining whether a virus can infect a human or other animal based on its genetic information is useful for assessing the threat level of circulating and newly emerging viruses. Previous studies in this domain have had access to limited datasets, and in this work we nearly double the amount of manually labelled host data for viral infection, so that others may build on it and improve it further. We use machine learning models to rank the likelihood of human and mammal infection for viruses in this improved dataset. Results are consistent with the determination of host infection being more tractable for broader categories of hosts, like mammals, than for specific species, like humans. This may suggest that the prospects are good for improved future models that first screen viruses based on their likelihood of infecting mammals, and then in a second stage for likelihood of human infection. The most challenging scenarios were for predictions of viruses that were not similar to viruses in the training data, and the question remains whether we can expect reasonable generalization of predictive models to completely new viruses given that, at the time of writing, viruses do not appear to share a common ancestor.

bioinformatics↗

Predicting Permeation of Compounds across the Outer Membrane of P. aeruginosa Using Molecular Descriptors: Advantages and Limitations

The ability of Gram-negative pathogens to adapt and protect themselves against antibiotics is a growing threat to public health. The low permeability of the outer membrane (OM) in combination with effective multidrug efflux pumps, constitute the two main antibiotic resistance mechanisms. Though much efforts have been devoted to discover new antibiotics that can bypass these defense mechanisms, no new antibiotic classes have been introduced into clinics in the last 35 years. Models that identify specific descriptors of molecular properties and predict the likelihood that a given compound is capable of successfully permeate the OM and inhibit bacterial growth while avoiding efflux could facilitate the discovery of novel classes of antibiotics. Here we evaluate 174 molecular descriptors of 1260 antimicrobial compounds and study their correlations with antibacterial activity in Gram-negative Pseudomonas aeruginosa. While part of these descriptors are computed using traditional approaches based on the physicochemical properties intrinsic to the compounds, ensemble docking and all-atom molecular dynamics (MD) simulations are used to derive additional bacterium-specific mechanistic properties. Descriptors of compound permeation across the OM were calculated using all-atom MD simulations of the compounds in different subregions of the OM model. Descriptors of interactions with efflux pumps were calculated from ensemble docking of compounds targeting specific binding pockets of MexB, the major efflux transporter of P. aeruginosa. Using these descriptors and the measured antibacterial inhibitory concentrations of compounds, we design and implement a statistical protocol to identify a subset of the molecular properties that are predictive of whether a given compound is a strong or weak permeator across the Gram-negative OM. Our results indicate that 88.4% of the compounds that show measurable antibacterial activity, follow very consistent rules of permeation, which highlight the critical role that the interaction between the compound and the OM have at predicting permeation. The remaining 11.6% of the compounds, although less predictive, are characterized by distinctive structural markers that can be used to minimize classification errors. An implementation of the permeation rules and the structural markers uncovered in our study is shown, and it demonstrates the accuracy of our approach in a set of previously unseen compounds. Taken together, our analysis sheds new light on the key molecular properties that drug candidates should have in order to be effective at OM permeation/inhibition of P. aeruginosa, and opens the gate to similar data-driven studies in other Gram-negative pathogens.

biophysics↗

Interaction of Amphiphilic Lipoarabinomannan with Host Carrier Lipoproteins in Tuberculosis Patients: Implications for Blood-based Diagnostics.

Lipoarabinomannan (LAM), an amphiphilic lipoglycan of the Mycobacterium tuberculosis cell wall, is a diagnostic target for tuberculosis. Previous work from our laboratory and others suggests that LAM is associated with host serum lipoproteins, which may in turn have implications for diagnostic assays. Our team has developed two serum assays for amphiphile detection: lipoprotein capture and membrane insertion. The lipoprotein capture assay relies on capture of the host lipoproteins, exploiting the biological association of host lipoprotein with microbial amphiphilic biomarkers to "concentrate" LAM. In contrast, the membrane insertion assay is independent of the association between pathogen amphiphiles and host lipoprotein association, and directly captures LAM based on its thermodynamic propensity for association with a supported lipid membrane, which forms the functional surface of an optical biosensor. In this manuscript, we explored the use of these assays for the detection of LAM in sera from adults whose tuberculosis status had been well-characterized using conventional microbiological tests, and endemic controls. Using the lipoprotein capture assay, LAM signal/noise ratios were >1.0 in 29/35 (83%) individuals with culture-confirmed active tuberculosis, 8/13 (62%) individuals with tuberculosis symptoms but no positive culture for M. tuberculosis, and 0/6 (0%) symptom-free endemic controls. To evaluate serum LAM levels without bias associated with potential differences in circulating host lipoprotein concentrations between individuals, we subsequently processed available samples to liberate LAM from associated host lipoprotein assemblies followed by direct detection of the pathogen biomarker using the membrane insertion approach. Using the membrane insertion assay, signal/noise for detection of serum LAM was greater than that observed using the lipoprotein capture method for culture-confirmed TB patients (6/6), yet remained negative for controls (2/2). Taken together, these results suggest that detection of serum LAM is a promising TB diagnostic approach. Further work is required to optimize assay performance and to decipher the implications of LAM/host lipoprotein associations for diagnostic assay performance and TB pathogenesis.

microbiology↗